AR and breast carcinoma: Since AR also has roles in other cancer entities, mostly in prostate and in breast cancer [58, 59], multiple inhibitors and antagonists of AR have been developed and trialed [60], yielding successful therapeutic targeting of the AR in these cancer entities [61, 62].